Evaluation of glomerular filtration rate using iohexol plasma clearance in critically ill patients with augmented renal creatinine clearance: A single-centre retrospective study. 2021

Magalie Collet, and Dany Hijazi, and Pauline Sevrain, and Romain Barthélémy, and Marc-Antoine Labeyrie, and Dominique Prié, and Nahid Tabibzadeh, and Alexandre Mebazaa, and Benjamin G Chousterman
From the Department of Anesthesiology and Critical care, Hôpital Lariboisière, DMU Parabol, FHU PROMICE, APHP.Nord (M-C, D-H, P-S, R-B, A-M, BG-C), Department of Interventional Neuroradiology, Hopital Lariboisière (MA-L), EA 7334 REMES (MA-L), Functional Exploration Department, Hôpital Necker, APHP.Centre, Université de Paris (D-P), Inserm U1151 (D-P), Department of Physiology, Hôpital Bichat, APHP.Nord (N-T), Inserm U1149 (N-T) and Inserm U942, Université de Paris, Paris, France (A-M, BG-C).

BACKGROUND Augmented renal creatinine clearance (ARC) (≥130 ml min-1 1.73 m-2) is frequent in intensive care unit (ICU) patients and may impact patient outcome. OBJECTIVE To compare glomerular filtration rate (GFR) measured with iohexol plasma clearance and creatinine clearance in critically ill patients with augmented renal clearance. METHODS Single-centre, retrospective study. METHODS French University Hospital ICU from November 2016 to May 2019. METHODS Adult patients with augmented renal clearance who had a measurement of iohexol plasma clearance. METHODS Agreement between 6 h creatinine clearance (6 h CrCl) and iohexol plasma clearance (GFRio). RESULTS Twenty-nine patients were included. The median 6 h creatinine clearance was 195 [interquartile range (IQR) 162 to 251] ml min-1 1.73 m-2 and iohexol clearance was 133 [117 to 153] ml min-1 1.73 m-2. Sixteen patients (55%) had hyperfiltration (clearance >130 ml min-1 1.73 m-2) measured with iohexol clearance. Mean bias between iohexol and creatinine clearance was -80 [limits of agreement (LoA) -216 to 56 ml min-1 1.73 m-2]. For Cockcroft and Gault Modification of Diet in Renal Disease equation (MDRD), Chronic Kidney Disease Epidemiology Collaboration equation (CKD-EPI) formulae, mean biases were, respectively -27 (LoA -99 to 45), -14 (LoA -86 to 59) and 15 (LoA -33 to 64) ml min-1 1.73 m-2. CONCLUSIONS In the present study, we found that in patients with augmented renal creatinine clearance, half of the patients do not have hyperfiltration using iohexol clearance measurements. We observed an important bias between 6 h CrCl and GFRio with large LoA. In critically patients with ARC, 6 h CrCl does not reliably estimate GFR and 6 h CrCl nearly systematically overestimates renal function. Comparison of creatinine-based GFR estimations and GFRio show acceptable bias but wide LoA.

UI MeSH Term Description Entries
D007472 Iohexol An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality. Compound 545,Exypaque,Iohexol 350,Nycodenz,Omnipaque
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D005919 Glomerular Filtration Rate The volume of water filtered out of plasma through glomerular capillary walls into Bowman's capsules per unit of time. It is considered to be equivalent to INULIN clearance. Filtration Rate, Glomerular,Filtration Rates, Glomerular,Glomerular Filtration Rates,Rate, Glomerular Filtration,Rates, Glomerular Filtration
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D016638 Critical Illness A disease or state in which death is possible or imminent. Critically Ill,Critical Illnesses,Illness, Critical,Illnesses, Critical

Related Publications

Magalie Collet, and Dany Hijazi, and Pauline Sevrain, and Romain Barthélémy, and Marc-Antoine Labeyrie, and Dominique Prié, and Nahid Tabibzadeh, and Alexandre Mebazaa, and Benjamin G Chousterman
September 2017, Clinical nephrology,
Magalie Collet, and Dany Hijazi, and Pauline Sevrain, and Romain Barthélémy, and Marc-Antoine Labeyrie, and Dominique Prié, and Nahid Tabibzadeh, and Alexandre Mebazaa, and Benjamin G Chousterman
November 2016, Clinical chemistry and laboratory medicine,
Magalie Collet, and Dany Hijazi, and Pauline Sevrain, and Romain Barthélémy, and Marc-Antoine Labeyrie, and Dominique Prié, and Nahid Tabibzadeh, and Alexandre Mebazaa, and Benjamin G Chousterman
June 2011, Critical care (London, England),
Magalie Collet, and Dany Hijazi, and Pauline Sevrain, and Romain Barthélémy, and Marc-Antoine Labeyrie, and Dominique Prié, and Nahid Tabibzadeh, and Alexandre Mebazaa, and Benjamin G Chousterman
November 2022, European journal of pediatrics,
Magalie Collet, and Dany Hijazi, and Pauline Sevrain, and Romain Barthélémy, and Marc-Antoine Labeyrie, and Dominique Prié, and Nahid Tabibzadeh, and Alexandre Mebazaa, and Benjamin G Chousterman
July 2018, Critical care (London, England),
Magalie Collet, and Dany Hijazi, and Pauline Sevrain, and Romain Barthélémy, and Marc-Antoine Labeyrie, and Dominique Prié, and Nahid Tabibzadeh, and Alexandre Mebazaa, and Benjamin G Chousterman
October 2023, Neurocritical care,
Magalie Collet, and Dany Hijazi, and Pauline Sevrain, and Romain Barthélémy, and Marc-Antoine Labeyrie, and Dominique Prié, and Nahid Tabibzadeh, and Alexandre Mebazaa, and Benjamin G Chousterman
May 2024, Pediatric nephrology (Berlin, Germany),
Magalie Collet, and Dany Hijazi, and Pauline Sevrain, and Romain Barthélémy, and Marc-Antoine Labeyrie, and Dominique Prié, and Nahid Tabibzadeh, and Alexandre Mebazaa, and Benjamin G Chousterman
March 1998, Renal failure,
Magalie Collet, and Dany Hijazi, and Pauline Sevrain, and Romain Barthélémy, and Marc-Antoine Labeyrie, and Dominique Prié, and Nahid Tabibzadeh, and Alexandre Mebazaa, and Benjamin G Chousterman
May 2021, The Journal of international medical research,
Magalie Collet, and Dany Hijazi, and Pauline Sevrain, and Romain Barthélémy, and Marc-Antoine Labeyrie, and Dominique Prié, and Nahid Tabibzadeh, and Alexandre Mebazaa, and Benjamin G Chousterman
December 2022, European journal of pediatrics,
Copied contents to your clipboard!